Search This Blog

Showing posts with label atherosclerosis. Show all posts
Showing posts with label atherosclerosis. Show all posts

Wednesday, 2 April 2014

Update on July 3-5 EACPT Cardiovascular Focus Meeting in the Netherlands

Following the well-attended EACPT international summer school in 2013 in Edinburgh, the next European Association for Clinical Pharmacology and Therapeutics [EACPT] update for young researchers is the 2014 EACPT Focus Meeting on 'Drugs to Fight Cardiovascular Damage'. The EACPT Focus Meeting will provide you with the opportunity to attend state of the art lectures from leading professionals and researchers, including hands-on workshops. 
Topics include ultrasound imaging of vascular injury (including a hands-on workshop), the microbiome and inflammation in the metabolic syndrome, targeting inflammation to prevent and treat atherosclerosis, diagnosis and therapy of adrenal hypertension, and protection against ischaemia-reperfusion injury.

This EACPT Cardiovascular Focus Meeting is of interest to clinical pharmacologists, pharmacologists, and other young scientists and clinicians interested in drug treatment of cardiovascular disease. You can listen here to podcasts with international delegates at the last EACPT summer meeting in Edinburgh in 2013.

The abstract deadline is April 15th - the top 5 ranked abstracts will be provided with free registration. Abstract submission is online on the Focus Meeting website. There are opportunities for both oral and poster presentations within the overall scientific program.  All abstracts presented at the meeting will be published in Clinical Therapeutics, the peer-reviewed Official Journal of the EACPT. 
Registration is now open - with preferential rates if you register by May 15th. A preferential accommodation rate is available through the Focus Meeting website.
The Scientific Programme is now online on the Focus Meeting website. The 2014 EACPT Focus Meeting takes place from July 3rd - 5th at the Radboud University Medical 
Radboud University Medical Centre, Nijmegen
Center in Nijmegen in the Netherlands. 
Visit the Clinical Therapeutics website.




Tuesday, 3 September 2013

Tabassome Simon discusses Clinical Pharmacology and the FAST-MI Registry

At the 11th EACPT Congress in Geneva, EACPT Vice-Chairman Professor Tabassome Simon from Paris discussed results on inflammatory mediators and outcomes of acute coronary syndromes, based on data from the French FAST-MI Registry.
In a podcast discussion with EACPT Secretary Donald Singer, Tabassome Simon discusses- the origins and significance of the FAST-MI French Registry of patients with acute coronary syndromes
- the contribution of Clinical Pharmacology to the success of FAST-MI 
- the strengths of including non-cardiological drugs in FAST-MI
- the strengths of bio-banking serological and genetic samples in FAST-MI

1. Listen to the podcast with Tabassome Simon about the origins and importance of the FAST-MI Registry.

2. Listen to Tabassome Simon discussing the role of Clinical Pharmacology in FAST-MI RegistryDownload transcript

FAST-MI collaborator Ziad Mallat with EACPT Vice-Chair Tabassome Simon and EACPT Secretary Donald Singer

Weblinks for selected FAST-MI publications


Around 600 young and senior pharmacologists and other delegates from 5 continents were in Geneva at the end of August, for the 11th biennial Congress of the European Association for Clinical Pharmacology and Therapeutics (EACPT). 


More about the 11th EACPT Congress in Geneva.
Paddle steamer by Hôtel de la Paix, Geneva

View and download Congress Programme
View Congress Abstracts ONLINE at the Clinical Therapeutics website.

The Geneva Congress brought together a wide range of international delegates, including health professionals, clinical and life scientists, policy makers, professionals from the biotechnology and pharmaceutical communities and others interested in the spectrum from basic to clinical pharmacology and pharmacotherapy, and from drug discovery to regulatory affairs. For the Geneva Congress, there were 101 invited speakers from 21 countries - 15 from the European region and a further 6 countries internationally, from the USA, Canada, New Zealand, China, Benin and India. Around 300 abstracts from 57 countries from all 5 continents were presented as oral and poster communications.

Future EACPT Congresses and Summer Schools
2014 - 11th EACPT Summer School - Nijmegen: 5-8 July
2015 - 12th EACPT Congress - Madrid
2017 - 13th EACPT Congress - Prague
2019 - 14th EACPT Congress - Stockholm  

Monday, 2 September 2013

Professor Ziad Mallat on immunotherapy vs. atherosclerosis at EACPT Geneva Congress

Professor Ziad Mallat (Cambridge, UK) gave one of the Keynote Lectures at the 11th EACPT Congress in Geneva. His theme was immunotherapy against atherosclerosis

In a podcast with EACPT Secretary Professor Donald Singer, Ziad Mallat 
- discusses how he became interested in this research question, 
- considers inflammatory therapeutic targets at early and later stages in the evolution of serious clinical vascular disease,
- explains the inflammasome and
- discusses options for targeting both soluble and cellular factors.

1. Listen to the podcast with Ziad Mallat about immunotherapy vs. atherosclerosis.

2. Listen to Ziad Mallat discussing how he became interested in a career in clinical research.

Ziad Mallat with EACPT Vice-Chair Tabassome Simon and EACPT Secretary Donald Singer


Around 600 young and senior pharmacologists and other delegates from 5 continents were in Geneva at the end of August, for the 11th biennial Congress of the European Association for Clinical Pharmacology and Therapeutics (EACPT). 



More about the 11th EACPT Congress in Geneva.
Paddle steamer by Hôtel de la Paix, Geneva

View and download Congress Programme
View Congress Abstracts ONLINE at the Clinical Therapeutics website.

The Geneva Congress brought together a wide range of international delegates, including health professionals, clinical and life scientists, policy makers, professionals from the biotechnology and pharmaceutical communities and others interested in the spectrum from basic to clinical pharmacology and pharmacotherapy, and from drug discovery to regulatory affairs. For the Geneva Congress, there were 101 invited speakers from 21 countries - 15 from the European region and a further 6 countries internationally, from the USA, Canada, New Zealand, China, Benin and India. Around 300 abstracts from 57 countries from all 5 continents were presented as oral and poster communications.

Future EACPT Congresses and Summer Schools
2014 - 11th EACPT Summer School - Nijmegen: 5-8 July
2015 - 12th EACPT Congress - Madrid
2017 - 13th EACPT Congress - Prague
2019 - 14th EACPT Congress - Stockholm